Results 21 to 30 of about 25,496 (206)

Tertiary lymphoid organs in central nervous system autoimmunity [PDF]

open access: yes, 2016
Multiple sclerosis (MS) is an autoimmune disease characterized by chronic inflammation in the central nervous system (CNS), which results in permanent neuronal damage and substantial disability in patients.
Mitsdoerffer, M., Peters, A.
core   +1 more source

Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer [PDF]

open access: yes, 2016
Tregs can contribute to tumor progression by suppressing antitumor immunity. Exceptionally, in human colorectal cancer (CRC), Tregs are thought to exert beneficial roles in controlling pro-tumor chronic inflammation.
BARNABA, Vincenzo   +14 more
core   +1 more source

Revisited role of B cells in atherosclerosis [PDF]

open access: yes, 2012
No abstract ...
Blair, Paula, Maffia, Pasquale
core   +1 more source

Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures [PDF]

open access: yesMelanoma Research, 2018
Desmoplastic melanomas (DM) have unique and challenging clinical presentations and histomorphology. A characteristic feature is the presence of scattered lymphoid aggregates. However, the nature of these aggregates is not defined. We hypothesized that they may be tertiary lymphoid structures (TLS), and may be associated with programmed death ligand 1 ...
Anne M, Stowman   +5 more
openaire   +2 more sources

High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function [PDF]

open access: yes, 2017
The blood vasculature regulates both the development and function of secondary lymphoid organs by providing a portal for entry of hemopoietic cells. During the development of lymphoid organs in the embryo, blood vessels deliver lymphoid tissue inducer ...
Ann Ager
core   +5 more sources

Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System

open access: yesFrontiers in Immunology, 2021
In the light of the success and the expected growth of its arsenal, immuno-therapy may become the standard neoadjuvant procedure for many cancers in the near future.
Christopher G. Mueller   +3 more
doaj   +1 more source

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor immunity, immunosuppression, or Bystander Sentinels in Disease? [PDF]

open access: yes, 2017
Secondary lymphoid organs are integral to initiation and execution of adaptive immune responses. These organs provide a setting for interactions between antigen-specific lymphocytes and antigen-presenting cells recruited from local infected or ...
Adachi   +151 more
core   +5 more sources

LLT1-CD161 Interaction in Cancer: Promises and Challenges

open access: yesFrontiers in Immunology, 2022
The success of immune checkpoint therapy in cancer has changed our way of thinking, promoting the design of future cancer treatments that places the immune system at the center stage.
Veronique M. Braud   +5 more
doaj   +1 more source

Perivascular adipose tissue inflammation in vascular disease [PDF]

open access: yes, 2017
Perivascular adipose tissue (PVAT) plays a critical role in the pathogenesis of cardiovascular disease. In vascular pathologies, perivascular adipose tissue increases in volume and becomes dysfunctional, with altered cellular composition and molecular ...
Guzik, Tomasz J., Nosalski, Ryszard
core   +1 more source

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response

open access: yesCancers, 2022
Since its first application in the treatment of cancer during the 1800s, immunotherapy has more recently become the leading edge of novel treatment strategies. Even though the efficacy of these agents can at times be predicted by more traditional metrics and biomarkers, often patient responses are variable.
Raj G. Vaghjiani, Joseph J. Skitzki
openaire   +2 more sources

Home - About - Disclaimer - Privacy